换肤

之江生物

i问董秘

A04022

主营介绍

  • 主营业务：

    分子诊断试剂的研发、生产和销售

  • 产品类型：

    妇科类、呼吸道类、肝炎、肠道及生殖道感染类、核酸提取类

  • 产品名称：

    高危型人乳头瘤病毒分型核酸测定试剂盒 、 呼吸道合胞病毒A 、 B分型核酸测定试剂盒 、 肺炎支原体及肺炎衣原体核酸联合检测试剂盒 、 乙型肝炎病毒核酸测定试剂盒 、 丙型肝炎病毒核酸定量测定试剂盒 、 肠道病毒通用型核酸测定试剂盒 、 肠道病毒71型核酸测定试剂盒 、 柯萨奇病毒16型核酸测定试剂盒 、 沙眼衣原体核酸测定试剂盒 、 磁珠 、 核酸提取试剂等

  • 经营范围：

    生物技术的研究开发,生物技术咨询,化学试剂(除危险化学品、监控化学品、烟花爆竹、民用爆炸物品、易制毒化学品)的零售;货物的进出口;医疗器械的销售(具体经营范围见许可证);III类6840医用体外诊断试剂的生产。【依法须经批准的项目,经相关部门批准后方可开展经营活动】

主营构成分析

报告期
报告期
{"2020-03-31":{"YYSR":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","15738.37"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","4965.19"],["\u5176\u4ed6","926.34"],["\u5176\u4ed6\u4e1a\u52a1","145.15"]],"3":[["\u534e\u4e1c","8419.22"],["\u534e\u5357","4204.39"],["\u534e\u4e2d","2446.38"],["\u534e\u5317","2025.24"],["\u5883\u5916","1683.93"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",2850.74]]},"YYCB":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","2100.21"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","2254.44"],["\u5176\u4ed6","148.49"],["\u5176\u4ed6\u4e1a\u52a1","25.37"]],"3":[["\u534e\u4e1c",""],["\u534e\u5357",""],["\u534e\u4e2d",""],["\u534e\u5317",""],["\u5883\u5916",""],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",0]]},"LRBL":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","79.08"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","15.72"],["\u5176\u4ed6","4.51"],["\u5176\u4ed6\u4e1a\u52a1","0.69"]],"3":[["\u534e\u4e1c",""],["\u534e\u5357",""],["\u534e\u4e2d",""],["\u534e\u5317",""],["\u5883\u5916",""],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",0]]}},"2019-12-31":{"YYSR":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","22122.12"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","2576.12"],["\u5176\u4ed6","727.38"]],"3":[["\u534e\u4e1c","9184.99"],["\u534e\u5317","5713.75"],["\u534e\u5357","3620.85"],["\u897f\u5357","2814.92"],["\u534e\u4e2d","2130.90"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",1960.21]]},"YYCB":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","4260.13"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","1610.86"],["\u5176\u4ed6","150.58"]],"3":[["\u534e\u4e1c",""],["\u534e\u5317",""],["\u534e\u5357",""],["\u897f\u5357",""],["\u534e\u4e2d",""],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",0]]},"LRBL":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","92.05"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","4.97"],["\u5176\u4ed6","2.97"]],"3":[["\u534e\u4e1c",""],["\u534e\u5317",""],["\u534e\u5357",""],["\u897f\u5357",""],["\u534e\u4e2d",""],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",0]]}},"2018-12-31":{"YYSR":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","20758.12"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","801.23"],["\u5176\u4ed6","516.23"]],"3":[["\u534e\u4e1c","8281.39"],["\u534e\u5317","6309.36"],["\u534e\u5357","2620.33"],["\u897f\u5357","2086.40"],["\u534e\u4e2d","1148.22"],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",1629.88]]},"YYCB":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","3535.04"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","457.85"],["\u5176\u4ed6","92.98"]],"3":[["\u534e\u4e1c",""],["\u534e\u5317",""],["\u534e\u5357",""],["\u897f\u5357",""],["\u534e\u4e2d",""],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",0]]},"LRBL":{"2":[["\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","95.74"],["\u5206\u5b50\u8bca\u65ad\u4eea\u5668","1.91"],["\u5176\u4ed6","2.35"]],"3":[["\u534e\u4e1c",""],["\u534e\u5317",""],["\u534e\u5357",""],["\u897f\u5357",""],["\u534e\u4e2d",""],["\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1",0]]}}}
{"YYSR":{"chartWrap2":[{"name":"\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[15738.37,22122.12,20758.12],"columnData":[72.28,87.01,94.03],"unit":["1.57\u4ebf","2.21\u4ebf","2.08\u4ebf"]},{"name":"\u5206\u5b50\u8bca\u65ad\u4eea\u5668","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[4965.19,2576.12,801.23],"columnData":[22.8,10.13,3.63],"unit":["4965.19\u4e07","2576.12\u4e07","801.23\u4e07"]},{"name":"\u5176\u4ed6","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[926.34,727.38,516.23],"columnData":[4.25,2.86,2.34],"unit":["926.34\u4e07","727.38\u4e07","516.23\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1","timeData":["2020-03-31"],"lineData":[145.15],"columnData":[0.67],"unit":["145.15\u4e07"]}],"chartWrap3":[{"name":"\u534e\u4e1c","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[8419.22,9184.99,8281.39],"columnData":[38.92,36.12,37.51],"unit":["8419.22\u4e07","9184.99\u4e07","8281.39\u4e07"]},{"name":"\u534e\u5357","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[4204.39,3620.85,2620.33],"columnData":[19.44,14.24,11.87],"unit":["4204.39\u4e07","3620.85\u4e07","2620.33\u4e07"]},{"name":"\u534e\u4e2d","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[2446.38,2130.9,1148.22],"columnData":[11.31,8.38,5.2],"unit":["2446.38\u4e07","2130.90\u4e07","1148.22\u4e07"]},{"name":"\u534e\u5317","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[2025.24,5713.75,6309.36],"columnData":[9.36,22.47,28.58],"unit":["2025.24\u4e07","5713.75\u4e07","6309.36\u4e07"]},{"name":"\u5883\u5916","timeData":["2020-03-31"],"lineData":[1683.93],"columnData":[7.79],"unit":["1683.93\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[2850.74,1960.21,1629.88],"columnData":[13.18,7.71,7.39],"unit":["2850.74\u4e07","1960.21\u4e07","1629.88\u4e07"]},{"name":"\u897f\u5357","timeData":["2019-12-31","2018-12-31"],"lineData":[2814.92,2086.4],"columnData":[11.07,9.45],"unit":["2814.92\u4e07","2086.40\u4e07"]}]},"YYCB":{"chartWrap2":[{"name":"\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[2100.21,4260.13,3535.04],"columnData":[46.38,70.75,86.52],"unit":["2100.21\u4e07","4260.13\u4e07","3535.04\u4e07"]},{"name":"\u5206\u5b50\u8bca\u65ad\u4eea\u5668","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[2254.44,1610.86,457.85],"columnData":[49.78,26.75,11.21],"unit":["2254.44\u4e07","1610.86\u4e07","457.85\u4e07"]},{"name":"\u5176\u4ed6","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[148.49,150.58,92.98],"columnData":[3.28,2.5,2.28],"unit":["148.49\u4e07","150.58\u4e07","92.98\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1","timeData":["2020-03-31"],"lineData":[25.37],"columnData":[0.56],"unit":["25.37\u4e07"]}],"chartWrap3":[{"name":"\u534e\u4e1c","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u534e\u5357","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u534e\u4e2d","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u534e\u5317","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u5883\u5916","timeData":["2020-03-31"],"lineData":[0],"columnData":[0],"unit":["0.00"]},{"name":"\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u897f\u5357","timeData":["2019-12-31","2018-12-31"],"lineData":[0,0],"columnData":[0,0],"unit":["0.00","0.00"]}]},"LRBL":{"chartWrap2":[{"name":"\u6838\u9178\u68c0\u6d4b\u8bd5\u5242\u76d2","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[79.08,92.05,95.74],"columnData":[79.08,92.05,95.74],"unit":["79.08\u4e07","92.05\u4e07","95.74\u4e07"]},{"name":"\u5206\u5b50\u8bca\u65ad\u4eea\u5668","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[15.72,4.97,1.91],"columnData":[15.72,4.97,1.91],"unit":["15.72\u4e07","4.97\u4e07","1.91\u4e07"]},{"name":"\u5176\u4ed6","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[4.51,2.97,2.35],"columnData":[4.51,2.97,2.35],"unit":["4.51\u4e07","2.97\u4e07","2.35\u4e07"]},{"name":"\u5176\u4ed6\u4e1a\u52a1","timeData":["2020-03-31"],"lineData":[0.69],"columnData":[0.69],"unit":["6900.00"]}],"chartWrap3":[{"name":"\u534e\u4e1c","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u534e\u5357","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u534e\u4e2d","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u534e\u5317","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u5883\u5916","timeData":["2020-03-31"],"lineData":[0],"columnData":[0],"unit":["0.00"]},{"name":"\u5176\u4ed6\u4e1a\u52a1\u603b\u8ba1","timeData":["2020-03-31","2019-12-31","2018-12-31"],"lineData":[0,0,0],"columnData":[0,0,0],"unit":["0.00","0.00","0.00"]},{"name":"\u897f\u5357","timeData":["2019-12-31","2018-12-31"],"lineData":[0,0],"columnData":[0,0],"unit":["0.00","0.00"]}]}}

营业收入 X

单位（%） 单位（万元）
注：通常在中报、年报时披露　
业务名称 营业收入(元) 收入比例 营业成本(元) 成本比例 利润比例 毛利率
按产品 核酸检测试剂盒 1.57亿 72.28% 2100.21万 46.38% 79.08% 86.66%
分子诊断仪器 4965.19万 22.80% 2254.44万 49.78% 15.72% 54.60%
其他 926.34万 4.25% 148.49万 3.28% 4.51% 83.97%
其他业务 145.15万 0.67% 25.37万 0.56% 0.69% 82.52%
按地区 华东 8419.22万 38.92% - - - -
华南 4204.39万 19.44% - - - -
华中 2446.38万 11.31% - - - -
华北 2025.24万 9.36% - - - -
境外 1683.93万 7.79% - - - -
西南 1523.57万 7.04% - - - -
东北 873.02万 4.04% - - - -
西北 454.15万 2.10% - - - -

董事会经营评述

一、商业模式
本公司是处于分子诊断行业的生产商，拥有快速的响应机制及成熟的注册体系、完善的研发平台及优秀的研发团队、丰富的产品系列及高效的转化能力、严格的质量管理及稳定的产品表现、优质的终端客户及良好的品牌形象，为国内众多三甲医院、第三方医学检验所、疾病预防控制中心及其他医疗机构提供分子诊断试剂及仪器设备。公司采取“直销和经销相结合”的销售模式，通过提供分子诊断试剂及仪器设备获得收入。
报告期内，公司的商业模式较上年度没有发生较大的变化。

二、经营情况回顾
　　报告期内，公司经营业绩得到了持续、快速增长。
　　在技术产品开发方面，公司继续加大技术创新力度，重点关注新技... 查看全部▼

一、商业模式
本公司是处于分子诊断行业的生产商，拥有快速的响应机制及成熟的注册体系、完善的研发平台及优秀的研发团队、丰富的产品系列及高效的转化能力、严格的质量管理及稳定的产品表现、优质的终端客户及良好的品牌形象，为国内众多三甲医院、第三方医学检验所、疾病预防控制中心及其他医疗机构提供分子诊断试剂及仪器设备。公司采取“直销和经销相结合”的销售模式，通过提供分子诊断试剂及仪器设备获得收入。
报告期内，公司的商业模式较上年度没有发生较大的变化。

二、经营情况回顾
　　报告期内，公司经营业绩得到了持续、快速增长。
　　在技术产品开发方面，公司继续加大技术创新力度，重点关注新技术、新产品开发，同时持续对已有技术产品优化开发，进一步丰富并优化公司产品线。
　　在市场营销方面，大力加快市场拓展步伐，进一步加强了市场竞争力，实现了公司销售收入的持续增长，不断扩大公司在分子诊断领域的影响力。
　　报告期内，在公司全体员工的共同努力下，公司主营业务保持较快增长，实现营业收入81,860.66万元，营业利润50,585.23万元及净利润42,781.53万元，较上年同期分别增长了523.50%、1288.78%及1259.16%。

三、风险与价值


四、企业社会责任
（一）精准扶贫工作情况
（二）其他社会责任履行情况
无。 收起▲

同花顺个股页面 | F10论坛 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。